05/16 | European ADRs Move Higher in Monday Trading | MT |
05/16 | NOVO NORDISK A/S : Share repurchase programme | GL |
05/16 | NOVO NORDISK A/S : Share repurchase programme | GL |
05/13 | U.S. FDA approves Eli Lilly's treatment for type 2 diabetes | RE |
05/12 | NOVO NORDISK : Barclays gives a Buy rating | MD |
05/11 | NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives and associa.. | GL |
05/11 | NOVO NORDISK : Deutsche Bank keeps its Buy rating | MD |
05/10 | Novo Nordisk Starts Research Collaboration With Flagship Pioneering | MT |
05/09 | Novo Nordisk - major shareholder announcement | AQ |
05/06 | NOVO NORDISK A/S : | GL |
05/06 | NOVO NORDISK A/S : | GL |
05/06 | NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives and associa.. | GL |
05/05 | Bryan Garnier Upgrades Novo Nordisk to Neutral From Sell | MT |
05/05 | TRANSCRIPT : Novo Nordisk A/S, Q1 2022 Earnings Call, May 05, 2022 | CI |
05/05 | NOVO NORDISK : Buy rating from Bernstein | MD |
05/05 | NOVO NORDISK : Goldman Sachs reiterates its Buy rating | MD |
05/04 | NOVO NORDISK : Deutsche Bank maintains a Buy rating | MD |
05/03 | Trading in Novo Nordisk shares by board members, executives and associated persons | GL |
05/03 | Trading in Novo Nordisk shares by board members, executives and associated persons | GL |
05/03 | Novo Nordisk A/S – Share repurchase programme | GL |
05/03 | Novo Nordisk A/S purchases B shares worth DKK 3,402 million from Novo Holdings A/S unde.. | GL |
05/03 | Novo Nordisk A/S purchases B shares worth DKK 3,402 million from Novo Holdings A/S unde.. | AQ |
05/03 | NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives and associa.. | GL |
05/03 | Novo Nordisk A/S – Share repurchase programme | GL |
05/03 | Novo Nordisk A/S – Share repurchase programme | GL |
05/03 | NOVO NORDISK : Gets a Buy rating from Deutsche Bank | MD |
05/02 | Novo Nordisk – major shareholder announcement | GL |
05/02 | NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives and associa.. | GL |
04/29 | SECTOR UPDATE : Health Care Stocks Mixed Premarket Friday | MT |
04/29 | European ADRs Nudge Higher in Friday Trading | MT |
04/29 | NOVO NORDISK : JP Morgan remains Neutral | MD |
04/29 | NOVO NORDISK : Jefferies reaffirms its Sell rating | MD |
04/29 | NOVO NORDISK : Bernstein maintains a Buy rating | MD |
04/29 | Novo Nordisk Posts Higher Q1 Earnings, Net Sales; Raises 2022 Profit, Sales Growth Targ.. | MT |
04/29 | TRANSCRIPT : Novo Nordisk A/S, Q1 2022 Earnings Call, Apr 29, 2022 | CI |
04/29 | Novo Nordisk A/S Reports Earnings Results for the First Quarter Ended March 31, 2022 | CI |
04/29 | Novo Nordisk lifts 2022 outlook after strong quarter, shares jump | RE |
04/29 | NOVO NORDISK : Goldman Sachs keeps its Buy rating | MD |
04/29 | NOVO NORDISK : Q1 Earnings Snapshot | AQ |
04/29 | Miners, earnings lift European stocks at end of choppy April | RE |
04/29 | Novo Nordisk Lifts FY22 Outlook as Q1 Profit Jumps 13% on Strong Demand for Diabetes Dr.. | MT |
04/29 | Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange .. | GL |
04/29 | Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange .. | GL |
04/29 | Novo Nordisk A/S Provides Earnings Guidance for the Full Year of 2022 | CI |
04/29 | Novo Nordisk Lifts Guidance and Expands Share Buyback as 1Q Earnings Beat | DJ |
04/28 | Novo Nordisk Says Phase 3a Trial of Insulin Icodec Achieves Primary Endpoint | MT |
04/28 | Novo Nordisk Achieves Primary Endpoint in Once-Weekly Insulin Icodec in Diabetes Study | MT |
04/28 | Once-weekly insulin icodec demonstrates superior reduction in HbA1c vs insulin degludec.. | GL |
04/28 | Novo Nordisk A/S Announces Once-Weekly Insulin Icodec Demonstrates Superior Reduction i.. | CI |
04/27 | European ADRs Nudge Higher in Wednesday Trading | MT |
04/27 | NOVO NORDISK : JP Morgan gives a Neutral rating | MD |
04/27 | Novo Nordisk A/S - Articles of Association | GL |
04/27 | Novo Nordisk A/S - Articles of Association | GL |
04/27 | Novo Nordisk A/S – Reduction of the share capital | GL |
04/27 | Novo Nordisk A/S – Reduction of the share capital | GL |
04/26 | Diagnos Announces Extension of Contract with Novo Nordisk For Follow-up of Diabetic Pat.. | MT |
04/26 | Diagnos Inc. Announces the Extension of Its Contract with Novo Nordisk | CI |
04/25 | TRANCHE UPDATE ON NOVO NORDISK A/S ( : NOVO B)'s Equity Buyback Plan announced on February.. | CI |
04/25 | Novo Nordisk A/S – Share repurchase programme | GL |
04/25 | Novo Nordisk A/S – Share repurchase programme | GL |
04/22 | Novo Nordisk Lands EU Drug Agency's Positive Scientific Opinion On Updating Storage Gui.. | MT |
04/22 | Novo Nordisk Says EMA Committee Backs NovoSeven Label Expansion | MT |
04/22 | Novo Nordisk Lands EU Committee's Positive Opinion For Postpartum Hemorrhage Treatment | MT |
04/21 | NOVO NORDISK : Buy rating from Bernstein | MD |
04/20 | THE ART OF STRATEGY EXECUTION : Howwe Technologies | AQ |
04/19 | NOVO NORDISK : Sell rating from Jefferies | MD |
04/14 | NOVO NORDISK : Berenberg remains Neutral | MD |
04/12 | NOVO NORDISK : Goldman Sachs reiterates its Buy rating | MD |
04/11 | Novo Nordisk A/S – Share repurchase programme | GL |
04/11 | Novo Nordisk A/S – Share repurchase programme | GL |
04/07 | European ADRs Move Lower in Thursday Trading | MT |
04/05 | European ADRs Move Lower in Tuesday Trading | MT |
04/04 | Novo Nordisk A/S – Share repurchase programme | GL |
04/04 | Novo Nordisk A/S – Share repurchase programme | GL |
04/01 | NOVO NORDISK : Goldman Sachs keeps its Buy rating | MD |